NCVH Shreveport - Multidisciplinary Advancements in the Treatment of Cardiovascular Disease, Peripheral Artery Disease and Endovascular Therapy 2017
In-Person Event
Feb 18, 2017
Shreveport, Louisiana, USASpeakers
OVERVIEW
NCVH Shreveport - Multidisciplinary Advancements in the Treatment of Cardiovascular Disease, Peripheral Artery Disease and Endovascular Therapy is organized by New Cardiovascular Horizons (NCVH) and would be held on Feb 18, 2017 at Shreveport Convention Center, Shreveport, Louisiana, United States of America.
The target audience for this medical event are Family Physicians, General Practice Physicians, Primary Care Providers, Internists, Cardiologists, Interventional Cardiologists, Vascular Medicine Specialists, Podiatrists, Cath Lab Technologists, Residents/Fellows, Physician Assistants, Advanced Practice Nurses, Nurses, Allied Health Professionals and Healthcare Administrators. This CME conference has been approved with a maximum of 6.25 AMA PRA Category 1 Credits.
Educational Highlights :
• Current Trends in Cardiovascular Medicine
• New Technologies for Venous Disease
• Multidisciplinary Evaluation and Treatment of PAD and CLI
• Pharmacotherapy Update and Management
Focused Educational Tracks to Include:
• Cardiovascular Update for the Primary Care Provider
• Contemporary Management for Podiatric Medicine and Wound Care Therapies
• Advanced Endovascular Arterial and Venous Techniques
Learning Objectives :
Upon completion of this program, participants should be able to:
• Summarize and implement the latest advances in technology, testing, and imaging for the diagnosis and management of cardiovascular disease.
• Discuss and apply new interventional tools and therapeutic options for the treatment of valvular heart disease, coronary artery disease, heart failure, and peripheral artery disease.
• Recognize and articulate the importance of peripheral artery disease diagnosis and its relationship to cardiovascular disease.
• Design pharmacotherapy goals for patients with a variety of secondary prevention cardiovascular risk factors.
• Evaluate endovascular techniques for below-the-knee interventions.
The target audience for this medical event are Family Physicians, General Practice Physicians, Primary Care Providers, Internists, Cardiologists, Interventional Cardiologists, Vascular Medicine Specialists, Podiatrists, Cath Lab Technologists, Residents/Fellows, Physician Assistants, Advanced Practice Nurses, Nurses, Allied Health Professionals and Healthcare Administrators. This CME conference has been approved with a maximum of 6.25 AMA PRA Category 1 Credits.
Educational Highlights :
• Current Trends in Cardiovascular Medicine
• New Technologies for Venous Disease
• Multidisciplinary Evaluation and Treatment of PAD and CLI
• Pharmacotherapy Update and Management
Focused Educational Tracks to Include:
• Cardiovascular Update for the Primary Care Provider
• Contemporary Management for Podiatric Medicine and Wound Care Therapies
• Advanced Endovascular Arterial and Venous Techniques
Learning Objectives :
Upon completion of this program, participants should be able to:
• Summarize and implement the latest advances in technology, testing, and imaging for the diagnosis and management of cardiovascular disease.
• Discuss and apply new interventional tools and therapeutic options for the treatment of valvular heart disease, coronary artery disease, heart failure, and peripheral artery disease.
• Recognize and articulate the importance of peripheral artery disease diagnosis and its relationship to cardiovascular disease.
• Design pharmacotherapy goals for patients with a variety of secondary prevention cardiovascular risk factors.
• Evaluate endovascular techniques for below-the-knee interventions.
KEY DATES
18 Feb, 2017
Event Start Date
18 Feb, 2017
Event End Date
SPECIALITIES
NeurologyCardiologyVascular SurgeryInterventional RadiologySUGGESTED HOTELS
CONFERENCE VENUE
Shreveport Convention CenterRELATED CONFERENCES & LIVE WEBINARS
Quick Links